Top Tickers by Strategy โ€” March 2026

Every month this site’s data pipeline pulls fresh market data from Yahoo Finance and recalculates strategy scores across more than 3,000 tickers. This roundup looks at who landed at the top of each strategy in the March 2026 dataset โ€” and what that actually tells us.

As always: these are scores, not recommendations. High scores mean a ticker fits a particular strategy’s profile well. They don’t mean it’s a good buy.


๐Ÿ’ฐ Dividend Daddy โ€” Top Yields, Elevated Risk

The Dividend Daddy strategy surfaces tickers with exceptional dividend yield and relatively low volatility. March’s top scorers are dominated by closed-end funds and mortgage REITs โ€” a recurring pattern that’s worth understanding before acting on.

TickerScoreDividend YieldBetaSector
OXLC100/10027.1%0.77Financial Services
ARR99/10016.1%1.42Real Estate
ABR99/10015.0%1.34Real Estate
ACP99/10017.3%0.79Financial Services
BCAT99/10020.5%โ€”Financial Services

What the data shows: Oxford Lane Capital (OXLC) leads with a 27.1% yield and a score of 100/100. It’s a leveraged closed-end fund focused on CLO equity tranches โ€” a category that generates extremely high cash distributions but carries meaningful credit and duration risk.

A yield of 27% from a stock priced under $6/share is the market’s way of saying something: either the cash flows are very high relative to NAV, or investors expect the distribution to be cut, or both. OXLC has historically maintained its distribution, but its net asset value has eroded over time. The Dividend Daddy score reflects the current yield and current volatility โ€” it doesn’t assess whether the distribution is sustainable.

The mortgage REITs (ARR, ABR) follow a similar pattern: high headline yields driven by leverage, with sensitivity to interest rate moves that raw beta numbers sometimes understate.

Takeaway: Dividend Daddy’s top scorers in March 2026 are income-heavy financial structures with meaningful complexity underneath. If you’re researching names from this list, understanding the fund structure or the REIT’s borrowing strategy is essential. The glossary entries for Dividend Yield and Beta are good starting points.


๐Ÿš€ Moon Shot โ€” High Beta, Volatile Momentum

The Moon Shot strategy targets tickers with high beta and signs of oversold momentum โ€” the profile of a volatile name that has pulled back and might have room to run. March 2026’s top scorers are concentrated in technology, fintech, and healthcare.

TickerScoreBetaRSISector
UMAC100/10022.2491.0Technology
AFRM99/1003.7340.6Financial Services
APLD99/1007.3445.6Technology
AS99/1002.8012.5Consumer Cyclical
BHVN99/1003.5336.7Healthcare

What the data shows: Unusual Machines (UMAC) leads with a beta of 22.24 โ€” a number that demands immediate scrutiny. A beta this high means the stock historically moves more than 22 times as much as the S&P 500 in any given period. This isn’t a sign of a healthy, established business; it reflects extreme price volatility, likely driven by low market cap, thin liquidity, and speculative trading patterns.

High Moon Shot scores like UMAC’s surface a question: is this oversold and ready to rebound, or is it a volatile small-cap with structural problems? The strategy doesn’t answer that โ€” it surfaces the signal and leaves the fundamental analysis to you.

The more established names here are more interesting from a research standpoint. Affirm (AFRM), a buy-now-pay-later fintech, has a beta of 3.73 and an RSI of 40.6 โ€” high growth exposure with moderate oversold conditions. Amer Sports (AS), the sports equipment company behind Salomon, Arc’teryx, and Wilson, has the most interesting pattern: a beta of 2.80 and an RSI of 12.5, suggesting a meaningful recent pullback in a consumer brand with real revenue.

Takeaway: Moon Shot’s scoring rewards high beta and oversold conditions, which naturally surfaces smaller, more volatile names at the top. Filter for companies with meaningful revenue before treating any of these as research candidates.


๐Ÿ”ช Falling Knife โ€” Oversold Below Moving Averages

The Falling Knife strategy identifies tickers whose price has declined sharply below both moving averages, with oversold RSI โ€” the setup sometimes called a “catch the falling knife” play in trading parlance. It’s a contrarian lens, not a value-investing one.

TickerScoreBetaRSISector
SMX100/100-2.8527.0Industrials
KWR99/100โ€”0.6Basic Materials
WGO99/100โ€”1.7Consumer Cyclical
MNRO99/100โ€”1.8Consumer Services
PATK99/100โ€”1.8Consumer Cyclical

What the data shows: March 2026’s Falling Knife leaders split into two groups worth distinguishing.

SMX (Security Matters Public Limited) scores 100/100 with a beta of -2.85 โ€” an unusual negative beta that means the stock tends to move inversely to the market. Paired with an RSI of 27, this is a deeply unusual technical setup. SMX is a tiny-cap industrial technology company; its high Falling Knife score reflects extreme technical distress more than investable opportunity.

The more intriguing names are the mid-cap consumer and industrial companies: Quaker Houghton (KWR), Winnebago Industries (WGO), Monro (MNRO), and Patrick Industries (PATK). All have RSIs below 2 โ€” among the lowest in the entire 3,000+ ticker dataset. These are established businesses with real revenues that have sold off heavily.

Whether a Falling Knife turns into a value recovery or a continued decline depends on why the knife is falling โ€” and that question requires fundamental research the strategy scores don’t provide.

Takeaway: The Falling Knife strategy gives you a list of tickers at or near technical extremes. The most interesting research question is whether the selloff reflects deteriorating fundamentals or an overreaction. See how RSI and moving averages work together in the glossary.


๐ŸŽˆ Over-Hyped โ€” Momentum at Its Most Extended

The Over-Hyped strategy flags tickers with very high RSI โ€” stocks that have run hard and may be overbought by recent momentum standards. Unlike the other strategies, this one is sometimes used as a potential short-side research tool: where is momentum most extended?

TickerScoreBetaRSISector
ACLX100/1000.2399.4Healthcare
AMPX99/1003.0790.0Industrials
VRE99/100โ€”96.1Real Estate
EHAB99/100โ€”94.7Healthcare
PTEN99/100โ€”93.3Energy

What the data shows: Arcellx (ACLX) leads with an RSI of 99.4 and a beta of only 0.23. This combination is unusual: extremely high recent momentum with very low historical market correlation. Arcellx is a clinical-stage biotech โ€” low beta is common in early-stage names where price action is driven by trial data rather than broad market moves. The near-perfect RSI suggests a significant catalyst or extended run.

Amprius Technologies (AMPX) shows the opposite pattern: high beta (3.07) and high RSI (90.0). This is the profile of a volatile small-cap riding a speculative move โ€” the kind of name where momentum can reverse sharply.

Takeaway: High Over-Hyped scores identify momentum extremes. Whether that means “about to reverse” or “about to continue higher” is a question no indicator can answer reliably. The strategy is most useful for identifying where to look for extended trades, not for making directional predictions.


๐Ÿ‹ Institutional Whale โ€” The Institutional-Quality Names

The Institutional Whale strategy identifies large-cap, high-volume stocks that meet the scale and liquidity requirements institutional investors need. March 2026’s top scorers are exactly what you’d expect: the largest and most liquid names in the market.

TickerScoreMarket CapRSISector
NVDA100/100$4.45T43.6Technology
AAPL99/100$3.76T37.7Technology
AMZN99/100$2.25T49.3Consumer Cyclical
ABBV99/100$398B50.8Healthcare
ASML99/100$531B38.1Technology

What the data shows: The Institutional Whale leaderboard is the most stable of the five strategies month-to-month โ€” it’s driven by market cap and volume, which change slowly for mega-caps. NVDA, AAPL, AMZN, and MSFT appear here every month.

What’s worth noting in March 2026 is the RSI readings: AAPL at 37.7 and NVDA at 43.6 indicate both have pulled back from recent highs. For analysts watching these names, the combination of institutional-scale quality and slightly oversold conditions is a pattern some use to time incremental positions.

ABBV (AbbVie) at $398B is a notable healthcare entry: a pharmaceutical company with a dividend yield of about 3% and a beta of 0.33 โ€” a very different risk/return profile than the tech-heavy rest of the list.

Takeaway: The Institutional Whale strategy is a filter, not a catalyst finder. It tells you “this stock is big enough and liquid enough to be on institutional radar.” What happens next depends on fundamentals, macro conditions, and market structure.


How to Use This Roundup

The value in a monthly roundup isn’t the specific names โ€” those will shift as data changes. It’s the patterns across strategies:

  • Dividend Daddy tends to surface closed-end funds and REITs. Know what you’re buying before chasing yield.
  • Moon Shot rewards extreme beta, which means it naturally surfaces speculative and small-cap names.
  • Falling Knife is best used as a research starting point, not an entry signal on its own.
  • Over-Hyped identifies momentum extremes that can run longer than expected โ€” or reverse sharply.
  • Institutional Whale is a quality and scale filter, stable over time.

For deeper background on how these scores are calculated, see the methodology page. For a guide to interpreting scores in combination, see How to Read the Five Strategies.


Data sourced from Yahoo Finance via daily pipeline. All figures as of March 2026. Nothing here constitutes financial advice.